Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020) - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Endocrine Année : 2020

Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020)

Yves Brault
  • Fonction : Auteur

Dates et versions

hal-03555792 , version 1 (03-02-2022)

Identifiants

Citer

Emmanuelle Kuhn, Philippe Caron, Brigitte Delemer, Isabelle Raingeard, Herve Lefebvre, et al.. Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study (September, 10.1007/s12020-020-02501-3, 2020). Endocrine, 2020, 71 (1), pp.265. ⟨10.1007/s12020-020-02532-w⟩. ⟨hal-03555792⟩
48 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More